Journal · Heart failure · Updated 22 November 2026
Current Heart Failure Reports
Read Current Heart Failure Reports articles on DeepDyve. No university library needed.
Current Heart Failure Reports publishes reviews on heart failure, from AI-enhanced electrocardiography for screening and digital tools for patient education to mineralocorticoid receptor antagonists and gut-related biomarkers. Springer Nature publishes it, and it has published since 2004. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Current Heart Failure Reports at a glance
- Full title
- Current Heart Failure Reports
- Abbreviation (NLM)
- Curr Heart Fail Rep
- Publisher
- Springer Nature
- Print ISSN
- 1546-9530
- Online ISSN (eISSN)
- 1546-9549
- First published
- 2004
- Subjects
- Cardiology
- Access model
- Hybrid (64% free to read in 2026)
Ways to access Current Heart Failure Reports
64% of the articles Current Heart Failure Reports published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 64% of Current Heart Failure Reports articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Current Heart Failure Reports. Check its journal list and whether it offers remote access.
- DeepDyve. Read Current Heart Failure Reports articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Current Heart Failure Reports’ 2025 Journal Impact Factor is 3.7, and its 5-year Impact Factor is 3.9.
3.7
Journal Impact Factor (2025)
3.9
5-year Impact Factor (2025)
9 days
Median time to first decision
Source: journal metrics on the Current Heart Failure Reports homepage (Springer Nature), checked November 22, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Current Heart Failure Reports research worth reading
Published January to March 2026. Summaries describe what the authors report.
-
Digital Solutions in HF Education: What Can Patients and Clinicians Gain?
The authors review digital tools for heart failure education, from remote platforms and interactive apps to AI-assisted learning and immersive reality, which can improve patient self-management and clinician learning, while noting challenges in equitable access, digital literacy and workflow integration.
Castiello et al. · Current Heart Failure Reports, published online January 9, 2026 · DOI 10.1007/s11897-025-00738-5
-
Artificial Intelligence-enhanced Electrocardiography for Heart Failure Screening and Risk Stratification
The authors review AI-enhanced electrocardiography for heart failure, describing models using 12-lead, image and wearable single-lead ECGs that predict new-onset heart failure about as well as established risk scores, and the standards and validation needed for clinical use.
Dhingra et al. · Current Heart Failure Reports, published online March 16, 2026 · DOI 10.1007/s11897-026-00748-x
-
Heart Failure with Preserved Ejection Fraction and Diastolic Dysfunction in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review
In a systematic review and meta-analysis, the authors report a pooled prevalence of diastolic dysfunction of 43.4% in COPD, worse prognosis when COPD and HFpEF coexist, and consistent treatment effects in three large trials in patients with and without COPD.
Segev et al. · Current Heart Failure Reports, published online February 2, 2026 · DOI 10.1007/s11897-025-00723-y
-
Evolving Mineralocorticoid Receptor Antagonism: a Narrative Review on Differences between Steroidal MRAs, Non-Steroidal MRAs and Aldosterone Synthase Inhibitors in Cardiorenal Disease
The authors review steroidal and non-steroidal mineralocorticoid receptor antagonists and emerging aldosterone synthase inhibitors in heart failure and chronic kidney disease, comparing their efficacy and safety, including problems such as hyperkalemia that limit use of steroidal agents.
Erzeel et al. · Current Heart Failure Reports, published online January 30, 2026 · DOI 10.1007/s11897-026-00740-5
-
Intestinal Fatty Acid Binding Protein (I-FABP) in Heart Failure: A Comprehensive Review of its Role as a Biomarker and Mediator in Cardiac Dysfunction
The authors review intestinal fatty acid-binding protein as a marker of gut injury in heart failure, noting that elevated levels are consistently linked with worse outcomes across acute, chronic and post-infarction heart failure and correlate with gut microbiota changes.
Mishra et al. · Current Heart Failure Reports, published online February 20, 2026 · DOI 10.1007/s11897-026-00747-y
Related journals
Questions about Current Heart Failure Reports
How can I read Current Heart Failure Reports articles without a subscription?
64% of Current Heart Failure Reports articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Current Heart Failure Reports articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Current Heart Failure Reports?
Current Heart Failure Reports’ NLM (PubMed) abbreviation is Curr Heart Fail Rep.
What is the ISSN of Current Heart Failure Reports?
The print ISSN is 1546-9530 and the online ISSN is 1546-9549.
What is the impact factor of Current Heart Failure Reports?
Current Heart Failure Reports’ Journal Impact Factor is 3.7 (2025), and its 5-year Impact Factor is 3.9, according to Springer Nature’s published metrics.
Is Current Heart Failure Reports open access?
Current Heart Failure Reports is a hybrid journal: authors can choose to publish open access or under the subscription model. From January 1 to November 20, 2026, 35 of 55 Current Heart Failure Reports articles (64%) carry a Creative Commons license, per Crossref.
Current Heart Failure Reports articles on DeepDyve are licensed from Springer Nature. Journal facts as of 22 November 2026.
Start reading Current Heart Failure Reports today
One month free, then less than $2 a day. Current Heart Failure Reports, plus millions of articles from thousands of journals.





